Human immunodeficiency virus (HIV) infections have been characterized by both polyclonal Bcell activation and enhanced responsiveness to B-cell growth factors on one hand and the loss of specific antibody (Ab) responses and refractoriness to the normal signals for B-cell activation on the other. Histopathological studies of lymph node from HIV-and simian immunodeficiency virus (SIV)-infected individuals have indicated initial follicular hyperplasia and the appearance of large irregular germinal centers that undergo progressive involution concomitant with follicular dendritic-cell (FDC) disruption. During this process, follicular dendritic-cell -enriched lymph-node-cell cultures exhibit increased ability to induce cluster formation ("in vitro germinal centers"), lymphocyte proliferation and antibody production compared to uninfected controls. This paper discusses how enhanced FDC-B-cell interaction within SIV-infected germinal centers may result in a reduced ability to select high-affinity B cells and alter the dynamics of antibodyproducing-cell and memory-cell generation resulting in the observed hyperactivity.
INTRODUCTION
In addition to the well-documented changes in the level and function of T cells, HIV infections also lead to dramatic qualitative and quantitative changes in the B cell compartment in terms of both function and the specificity of the antibody molecules produced. In vivo abnormalities in B-cell function include polyclonal B-cell activation, hypergammaglobulinaemia, increased levels of autoantibodies, decreased ability to mount antigen (Ag)-specific responses, and premature loss of specific anti-HIV antibodies (Zolla-Pazner, 1984; Mizuma et al., 1988; Amadori and Chieco-Bianchi, 1990; Fenouillet et al., 1992) . Accordingly, cultured peripheral blood mononuclear cells (PBMC) from seropositive patients secrete antibodies to HIV-and non-HIV-related antigens, spontaneously or following culture with HIV, and interleukins (IL), and exhibit decreased responsiveness to mitogens (Amadori et al., 1989; Edelman and *Corresponding author. Zolla-Pazner, 1991; Delfraissy et al., 1992; Shirai et al., 1992) . Although the observed polyclonal B-cell activation occurs early and persists throughout infection, it is thought to be independent of the specific humoral anti-HIV response, which clearly predominates during asymptomatic infection, as evidenced by large number of B cells spontaneously secreting anti-HIV antibodies in patient blood (Amadori et al., 1989; Shirai et al., 1992) , bone marrow (BM) , and duodenum (Eriksson et al., 1995) . In addition, antibody-secreting cells (ASC) specific for HIV proteins and peptides have also been detected around follicles and in the medulla in HIV+LN biopsies (Laman et al., 1989) . In vitro, the generation of HIV-and cytokine-(e.g., IL-6, IL-2 plus interferon-ce [IFN-ce] ) induced anti-HIV ASC in PBMC cultures derived from HIV-seropositive but not -seronegative individuals further illustrates extensive in vivo activation and expansion of HIV-specific B cells (Amadori et al., 1991; Delfraissy et al., 1992; Chirmule et al., 1993) .
During the course of disease, which varies amongst individuals, the number of anti-HIV ASC in blood and the levels of serum antibody specific for particular HIV determinants decline. Although the loss of certain specificities, for example, anti-p24, has been associated with disease progression, the duration of specific responses usually has not been shown to correlate with clinical, immunological, or virologic parameters (Yarchoan et al., 1986; Shirai et al., 1992; Binley et al., 1997) . In contrast, the increase in polyclonal B-cell activation has been shown to have statistical significance among patients with advanced disease. Thus, in studies using PBMC by Shirai et al. (1992) , high HIV envelope gpl60-and gag p24-specific B-cell activation decreased, whereas polyclonal B-cell activation, as measured by the appearance of B-cell secreting anti-TNP and anti-DNA IgG antibodies increased during late-stage disease (CDC class IV). Likewise, the in vitro generation of HIV-ASC from PBMC from late-stage patients was also greatly reduced (Delfraissy et al., 1992) . How this transition relates to the process by which ASC are generated and selected from B-cell precursors in lymphoid organs and how this loss in ASC reflects similar changes in tissues are critical to our understanding of AIDS pathogenesis.
In this context, histopathological studies on HIV/ SIV organs have revealed dramatic changes in the follicles (B-cell area) of lymphoid organs that represent a dynamic process progressing from follicular hyperplasia to follicular involution (Biberfeld et al., 1986; Racz et al., 1986; Vago et al., 1989; Persidsky et al., 1995) (Kraal et al., 1982; Jacob et al., 1991; Liu et al., 1992; Apel and Berek, 1996; Liu and Banchereau, 1996) , also themselves undergo initial hypertrophy and subsequent fragmentation of their reticular networks. Although these alterations are not specific for HIV/SIV infections (Janossy et al., 1991; Rideout et al., 1992) (1) Initially, depending on the B-cell repertoire of the individual, less stringent selection might result in an overall decrease in the percentage of total effective anti-HIV ASC, whereas that for other B-cell specificities might increase; and (2) whereas anti-gpl20 antibody responses would be maintained at relatively high levels, those specific for monomeric soluble proteins, would remain low or be lost due to displacement from the FDC or an inability (Binley et al., 1997) ; and (3) in studies using duodenal biopsies from AIDS patients, a marked decrease in the numbers of ASC specific for the soluble antigens keyhole limpet hemocyanin and dog serum albumin in the absence of any decline in the percent antigp160 ASC (Eriksson et al., 1995) .
(ii) Increased Expression of Adhesion and Activation Molecules on B Cells and FDC Cytokines play a critical role in mediating immune function; the pattern of cytokine production determining the type of immune response generated. In addition, cytokines such as IFN-y and turnout necrosis factor-c (TNF-c0 are known to induce chemokines (Ebnet et al., 1996) (Persidsky et al., 1995) . Although increases in cells producing IL-1, IL-4, IL-6, TNF-c, and IFN-y have been reported in LN and blood from HIV and SIV-infected individuals (Emilie et al., 1990; Fan et al., 1993; Graziosi et al., 1994; Rosenberg et al., 1994a; Persidsky et al., 1995) , a comparison with the appropriate control LN or blood from uninfected monkeys or from humans with HIVunrelated hyperplasia has indicated to date that only IFN-y production is consistently increased throughout infection.
Another alteration observed in GC of HIV-infected LN is the greatly increased expression of CD23 antigen in the expanded part of the "dark" zone: CD23 being expressed normally only on FDC and B cells in the apical light zone. This CD23 positivity, which may result from IL-4 synthesis or increased numbers of immune complexes or FDC (Maeda et al., 1992) may increase signalling to B cells via interaction with CD21 (Bonnefoy et al., 1993) and may skew the maturation of B cells into plasma cells rather than memory cells (Liu and Banchereau, 1996) . Regardless of whether binding of integrins with their ligands or CD23 with CD21 is able to generate maturation signals in vivo (Liu et al., 1992; Bonnefoy et al., 1993; Adams et al., 1994; Lub et al., 1995; Liu and Banchereau, 1996) , it is possible that such interactions may augment low-affinity binding of IL-4 and IL-10 (Liu and Banchereau, 1996) , or via nonspecific T-cell-derived signals, eg., TNF-ce and IL-2 (Macchia et al., 1993 (Montaner, 1994) , the evidence to date shows no obvious reduction in IL-10 levels in LN or blood during HIV infection. The high levels of IgG produced during HIV/SIV infections indicate that sufficient T-cell help is present to induce isotype switching.
In the case of nonspecific signaling, TNF-ce, produced by CD4 cells from HIV patients or infected cells in vitro, is able to induce IgG production by syngeneic (presumably activated) B cells (Macchia et al., 1993) Hir et al., 1996; Matsumoto et al., 1996) , IL-6 is produced by FDC (M. K.-V., unpublished observation) and is important in spontaneous anti-HIV production by B cells (Amadori et al., 1991; Delfraissy et al., 1992) . Furthermore TNF-c and IL-6 cytokines have also been closely linked with increased HIV and SIV replication (Birx et al., 1993; Scala et al., 1994; Virelizier, 1994) , thereby increasing antigen levels.
Finally, it is noteworthy that whereas B cells constitute roughly 30% of total lymphocytes in the body, usually only 10-20% of the 1-2% of lymphocytes that circulate in the blood at any time are B cells (Westermann and Pabst, 1992) . Thus the usual sampling of PBMC may not be an accurate means of assessing overall B-cell function. Accordingly, (1) the number of peripheral blood B cells secreting anti-gp-160 antibody shows no significant correlation with serum anti-HIV gp-160 antibody concentrations (Schwartz et al., 1994) ; (2) BM contains >30-fold more anti-gpl60 ASC than blood following immunization with gp160 ; and (3) levels of HIV-specific ASC in duodenal biopsies and BM are present in large numbers throughout infection when numbers in blood are very low (Eriksson et al., 1995) . These results emphasize the need to examine tissues and not just blood in order to elucidate the mechanisms underlying the observed hyperactivity. In this context, another caveat arises because during the budding process, HIV virions become enveloped by the lipid bilayer of the host cell and simultaneously by many host-cell proteins (Arthur et al., 1992; Meerloo et al., 1993; Dierich, unpublished observation) . The extent to which such molecules may be responsible for the increased expression of adhesion and activation molecules and receptors as well as enhanced effector function observed in HIV+ GC are currently only beginning to be understood.
MATERIALS AND METHODS

Animals and Infections
Rhesus macaques were infected with 1-10 tissue culture infectious doses 50 (TCIDso) of SIV-251 and sacrificed between days 93 and 535, at which time mesenteric LN were removed for assaying. Control LN were collected from rhesus and pig-tailed macaques (Regional Primate Center, Seattle, WA). Schnizlein et al. (1985) with modifications (Kosco et al., 1992; Rosenberg et al. 1997 ). Cultured cells were analyzed phenotypically by FCM and for their proliferative ability by the incorporation of [3H]-TdR following a 6-8-hr pulse. In some cases, 1-ml cultures (2.5 10 6 cells/well) were set up and 100-/xl aliquots from each of three wells were pulsed with [3H]-TdR before harvesting producing similar results. Other control cultures were comprised of single-cell suspensions produced by passing a portion of the same unfractionated LN through a sieve; such mechanical disruption results in the destruction of the FDC (Schnizlein et al., 1985) . Although the latter controls may be suboptimal due to a loss of plasma cells and blasts noted using this method, the rapid loss of LN cells with highbackground incorporation in some of these FDCdeprived cultures served to indicate the important role of FDC in sustaining proliferation.
Immunoglobulin and Anti-SIV Antibody Assays IgG1 levels and anti-SIV antibody levels were measured using commercial ELISA kits, which cross react with macaque immunoglobulin obtained from The Binding Site (Birmingham, UK) and Genetic Systems (Seattle, WA).
